ArticleAllergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology2025

Anti-IL-5 and anti-IL-5 receptor therapy significantly improves quality of life and FEV1 values in patients with severe asthma.

Anaiza Odalis Villalobos Alfaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.